Merit Medical Systems

MMSI

Market cap $5.13B

Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Conmed (CNMD) or Merit Medical (MMSI). But which of these two stocks presents investors with the better value opportunity right now?

Merit Medical (MMSI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Small-cap stocks extended their momentum into the third quarter. We believe Rambus' evolution from a licensing and patent company into a full-fledged product company is progressing well. Shake Shack stock pulled back following quarterly results that did not meet elevated expectations.

Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Conmed (CNMD) or Merit Medical (MMSI). But which of these two stocks is more attractive to value investors?

SOUTH JORDAN, Utah, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced 24-month efficacy findings from the non-randomized AVG cohort of the WAVE trial. Results of the AVG cohort were presented during the Late-Breaking Clinical Trials session at the annual VIVA Foundation3 Venous Endovascular Interventional Strategies (VEINS) conference held in Las Vegas, NV.

MMSI beats third-quarter 2025 estimates on strong revenue and margin growth, prompting a raised full-year outlook across segments.

Merit Medical Systems, Inc. ( MMSI ) Q3 2025 Earnings Call October 30, 2025 5:00 PM EDT Company Participants Martha Aronson - President, CEO & Director Brian Lloyd - Chief Legal Officer & Corporate Secretary Raul Parra - CFO & Treasurer Conference Call Participants Jason Bednar - Piper Sandler & Co., Research Division Lilia-Celine Lozada - JPMorgan Chase & Co, Research Division Jayson Bedford - Raymond James & Associates, Inc., Research Division Michael Matson - Needham & Company, LLC, Research Division John Young - Canaccord Genuity Corp., Research Division David Rescott - Robert W. Baird & Co. Incorporated, Research Division Michael Petusky - Barrington Research Associates, Inc., Research Division James Sidoti - Sidoti & Company, LLC Presentation Operator Thank you for standing by, and welcome to the Merit Medical Systems Third Quarter 2025 Earnings Conference Call.

While the top- and bottom-line numbers for Merit Medical (MMSI) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Merit Medical (MMSI) came out with quarterly earnings of $0.92 per share, beating the Zacks Consensus Estimate of $0.82 per share. This compares to earnings of $0.86 per share a year ago.

Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Merit Medical (MMSI) or Straumann Holding AG (SAUHY). But which of these two companies is the best option for those looking for undervalued stocks?